Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
02 2023
Historique:
received: 29 08 2022
revised: 28 09 2022
accepted: 19 10 2022
pubmed: 30 10 2022
medline: 4 2 2023
entrez: 29 10 2022
Statut: ppublish

Résumé

In repaired tetralogy of Fallot (TOF), little is known about characteristics of patients with rapid ventricular tachycardia (VT). Also, whether patients with a first episode of nonrapid VT may subsequently develop rapid VT or ventricular fibrillation (VF) has not been addressed. The objectives of this study were to compare patients with rapid VT/VF with those with nonrapid VT and to assess the evolution of VT cycle lengths (VTCLs) overtime. Data were analyzed from a nationwide registry including all patients with TOF and implantable cardioverter-defibrillator (ICD) since 2000. Patients with ≥1 VT episode with VTCL ≤250 ms (240 beats/min) formed the rapid VT/VF group. Of 144 patients (mean age 42.0 ± 12.7 years; 104 [72%] men), 61 (42%) had at least 1 VT/VF episode, including 28 patients with rapid VT/VF (46%), during a median follow-up of 6.3 years (interquartile range 2.2-10.3 years). Compared with patients in the nonrapid VT group, those in the rapid VT/VF group were significantly younger at ICD implantation (35.2 ± 12.6 years vs 41.5 ± 11.2 years; P = .04), had more frequently a history of cardiac arrest (8 [29%] vs 2 [6%]; P = .02), less frequently a history of atrial arrhythmia (11 [42%] vs 22 [69%]; P = .004), and higher right ventricular ejection fraction (43.3% ± 10.3% vs 36.6% ± 11.2%; P = .04). The median VTCL of VT/VF episodes was 325 ms (interquartile range 235-429 ms). None of the patients with a first documented nonrapid VT episode had rapid VT/VF during follow-up. Patients with TOF and rapid VT/VF had distinct clinical characteristics. The relatively low variation of VTCL over time suggests a room for catheter ablation without a backup ICD in selected patients with well-tolerated VT.

Sections du résumé

BACKGROUND
In repaired tetralogy of Fallot (TOF), little is known about characteristics of patients with rapid ventricular tachycardia (VT). Also, whether patients with a first episode of nonrapid VT may subsequently develop rapid VT or ventricular fibrillation (VF) has not been addressed.
OBJECTIVES
The objectives of this study were to compare patients with rapid VT/VF with those with nonrapid VT and to assess the evolution of VT cycle lengths (VTCLs) overtime.
METHODS
Data were analyzed from a nationwide registry including all patients with TOF and implantable cardioverter-defibrillator (ICD) since 2000. Patients with ≥1 VT episode with VTCL ≤250 ms (240 beats/min) formed the rapid VT/VF group.
RESULTS
Of 144 patients (mean age 42.0 ± 12.7 years; 104 [72%] men), 61 (42%) had at least 1 VT/VF episode, including 28 patients with rapid VT/VF (46%), during a median follow-up of 6.3 years (interquartile range 2.2-10.3 years). Compared with patients in the nonrapid VT group, those in the rapid VT/VF group were significantly younger at ICD implantation (35.2 ± 12.6 years vs 41.5 ± 11.2 years; P = .04), had more frequently a history of cardiac arrest (8 [29%] vs 2 [6%]; P = .02), less frequently a history of atrial arrhythmia (11 [42%] vs 22 [69%]; P = .004), and higher right ventricular ejection fraction (43.3% ± 10.3% vs 36.6% ± 11.2%; P = .04). The median VTCL of VT/VF episodes was 325 ms (interquartile range 235-429 ms). None of the patients with a first documented nonrapid VT episode had rapid VT/VF during follow-up.
CONCLUSION
Patients with TOF and rapid VT/VF had distinct clinical characteristics. The relatively low variation of VTCL over time suggests a room for catheter ablation without a backup ICD in selected patients with well-tolerated VT.

Identifiants

pubmed: 36309156
pii: S1547-5271(22)02573-5
doi: 10.1016/j.hrthm.2022.10.016
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03837574']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-260

Informations de copyright

Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Mikael Laredo (M)

Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.

Guillaume Duthoit (G)

Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.

Frédéric Sacher (F)

LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.

Frédéric Anselme (F)

Rouen University Hospital, Rouen, France.

Caroline Audinet (C)

Bretagne Sud Hospital, Lorient, France.

Francis Bessière (F)

Louis Pradel Hospital, Lyon, France.

Pierre Bordachar (P)

LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.

Abdeslam Bouzeman (A)

Parly II Private Hospital, Le Chesnay, France.

Serge Boveda (S)

Pasteur Clinic, Toulouse, France.

Sok Sithikun Bun (SS)

Princess Grace Hospital, Monaco, France.

Morgane Chassignolle (M)

Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France.

Gaël Clerici (G)

Saint Pierre University Hospital, La Réunion, France.

Antoine Da Costa (A)

Saint Etienne University Hospital, Saint Etienne, France.

Maxime de Guillebon (M)

Pau Hospital, Pau, France.

Pascal Defaye (P)

Grenoble University Hospital, Grenoble, France.

Nathalie Elbaz (N)

Henri-Mondor University Hospital, Créteil, France.

Romain Eschalier (R)

Clermont Ferrand University Hospital, Clermont Ferrand, France.

Fabrice Extramiana (F)

Bichat University Hospital, Paris, France.

Laurent Fauchier (L)

Tours University Hospital, Tours, France.

Alexis Hermida (A)

Amiens University Hospital, Amiens, France.

Estelle Gandjbakhch (E)

Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.

Rodrigue Garcia (R)

Poitiers University Hospital, Poitiers, France.

Jean-Baptiste Gourraud (JB)

Nantes University Hospital, Nantes, France.

Charles Guenancia (C)

Dijon University Hospital, Dijon, France.

Benoit Guy-Moyat (B)

Limoges University Hospital, Limoges, France.

Didier Irles (D)

Annecy Hospital, Annecy, France.

Laurence Iserin (L)

Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France.

François Jourda (F)

Auxerre Hospital, Auxerre, France.

Linda Koutbi (L)

La Timone Hospital, Marseille, France.

Fabien Labombarda (F)

Caen University Hospital, Caen, France.

Magalie Ladouceur (M)

Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France; Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France.

Philippe Lagrange (P)

Saint-Pierre Clinic, Perpignan, France.

Nicolas Lellouche (N)

Henri-Mondor University Hospital, Créteil, France.

Jacques Mansourati (J)

Brest University Hospital, Brest, France.

Christelle Marquié (C)

Lille University Hospital, Lille, France.

Raphael Martins (R)

Rennes University Hospital, Rennes, France.

Grégoire Massoulié (G)

Clermont Ferrand University Hospital, Clermont Ferrand, France.

Amel Mathiron (A)

Amiens University Hospital, Amiens, France.

Philippe Maury (P)

Toulouse University Hospital, Toulouse, France.

Anne Messali (A)

Bichat University Hospital, Paris, France.

Antoine Milhem (A)

La Rochelle Hospital, La Rochelle, France.

Pierre Mondoly (P)

Toulouse University Hospital, Toulouse, France.

Cédric Nguyen (C)

Chalon sur Saône Hospital, Chalon sur Saône, France.

Sandro Ninni (S)

Lille University Hospital, Lille, France.

Jean Luc Pasquié (JL)

Montpellier University Hospital, Montpellier, France.

Bertrand Pierre (B)

Tours University Hospital, Tours, France.

Penelope Pujadas (P)

Les Franciscaines Clinic, Nîmes, France.

Jean-Marc Sellal (JM)

Nancy University Hospital, Nancy, France.

Jean-Benoit Thambo (JB)

LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.

Camille Walton (C)

Louis Pradel Hospital, Lyon, France.

Pierre Winum (P)

Nîmes University Hospital, Nîmes, France.

Cyril Zakine (C)

Saint-Gatien Clinic, Tours, France.

Alexandre Zhao (A)

Ambroise Paré Clinic, Neuilly, France.

Xavier Jouven (X)

Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France; Cardiac Electrophysiology Section, European Georges Pompidou Hospital, Paris, France.

Nicolas Combes (N)

Pasteur Clinic, Toulouse, France.

Eloi Marijon (E)

Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France; Cardiac Electrophysiology Section, European Georges Pompidou Hospital, Paris, France.

Victor Waldmann (V)

Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France; Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France; Cardiac Electrophysiology Section, European Georges Pompidou Hospital, Paris, France. Electronic address: victor.waldmann@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH